chr17-80110889-C-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000152.5(GAA):c.1551+49C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.706 in 1,612,730 control chromosomes in the GnomAD database, including 405,548 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.65 ( 33381 hom., cov: 32)
Exomes 𝑓: 0.71 ( 372167 hom. )
Consequence
GAA
NM_000152.5 intron
NM_000152.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.37
Publications
15 publications found
Genes affected
GAA (HGNC:4065): (alpha glucosidase) This gene encodes lysosomal alpha-glucosidase, which is essential for the degradation of glycogen to glucose in lysosomes. The encoded preproprotein is proteolytically processed to generate multiple intermediate forms and the mature form of the enzyme. Defects in this gene are the cause of glycogen storage disease II, also known as Pompe's disease, which is an autosomal recessive disorder with a broad clinical spectrum. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
GAA Gene-Disease associations (from GenCC):
- glycogen storage disease IIInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen, G2P
- glycogen storage disease due to acid maltase deficiency, infantile onsetInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- glycogen storage disease due to acid maltase deficiency, late-onsetInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 17-80110889-C-A is Benign according to our data. Variant chr17-80110889-C-A is described in CliVar as Benign. Clinvar id is 255352.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110889-C-A is described in CliVar as Benign. Clinvar id is 255352.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110889-C-A is described in CliVar as Benign. Clinvar id is 255352.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110889-C-A is described in CliVar as Benign. Clinvar id is 255352.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110889-C-A is described in CliVar as Benign. Clinvar id is 255352.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110889-C-A is described in CliVar as Benign. Clinvar id is 255352.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110889-C-A is described in CliVar as Benign. Clinvar id is 255352.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110889-C-A is described in CliVar as Benign. Clinvar id is 255352.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110889-C-A is described in CliVar as Benign. Clinvar id is 255352.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110889-C-A is described in CliVar as Benign. Clinvar id is 255352.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110889-C-A is described in CliVar as Benign. Clinvar id is 255352.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110889-C-A is described in CliVar as Benign. Clinvar id is 255352.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110889-C-A is described in CliVar as Benign. Clinvar id is 255352.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110889-C-A is described in CliVar as Benign. Clinvar id is 255352.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110889-C-A is described in CliVar as Benign. Clinvar id is 255352.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110889-C-A is described in CliVar as Benign. Clinvar id is 255352.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110889-C-A is described in CliVar as Benign. Clinvar id is 255352.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110889-C-A is described in CliVar as Benign. Clinvar id is 255352.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110889-C-A is described in CliVar as Benign. Clinvar id is 255352.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.73 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.654 AC: 99382AN: 151852Hom.: 33367 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
99382
AN:
151852
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.669 AC: 167863AN: 250994 AF XY: 0.683 show subpopulations
GnomAD2 exomes
AF:
AC:
167863
AN:
250994
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.711 AC: 1038667AN: 1460758Hom.: 372167 Cov.: 38 AF XY: 0.712 AC XY: 517372AN XY: 726768 show subpopulations
GnomAD4 exome
AF:
AC:
1038667
AN:
1460758
Hom.:
Cov.:
38
AF XY:
AC XY:
517372
AN XY:
726768
show subpopulations
African (AFR)
AF:
AC:
17782
AN:
33458
American (AMR)
AF:
AC:
21850
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
AC:
20439
AN:
26130
East Asian (EAS)
AF:
AC:
22223
AN:
39694
South Asian (SAS)
AF:
AC:
57445
AN:
86236
European-Finnish (FIN)
AF:
AC:
40810
AN:
53306
Middle Eastern (MID)
AF:
AC:
4584
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
810779
AN:
1111110
Other (OTH)
AF:
AC:
42755
AN:
60352
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
18950
37900
56849
75799
94749
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
19892
39784
59676
79568
99460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.654 AC: 99426AN: 151972Hom.: 33381 Cov.: 32 AF XY: 0.652 AC XY: 48433AN XY: 74274 show subpopulations
GnomAD4 genome
AF:
AC:
99426
AN:
151972
Hom.:
Cov.:
32
AF XY:
AC XY:
48433
AN XY:
74274
show subpopulations
African (AFR)
AF:
AC:
21920
AN:
41454
American (AMR)
AF:
AC:
8496
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
2673
AN:
3468
East Asian (EAS)
AF:
AC:
2763
AN:
5136
South Asian (SAS)
AF:
AC:
3151
AN:
4820
European-Finnish (FIN)
AF:
AC:
8199
AN:
10576
Middle Eastern (MID)
AF:
AC:
250
AN:
294
European-Non Finnish (NFE)
AF:
AC:
49983
AN:
67932
Other (OTH)
AF:
AC:
1401
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1683
3365
5048
6730
8413
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
800
1600
2400
3200
4000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2012
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Glycogen storage disease, type II Benign:1
Jun 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.